Clinical trial · Observational
Detection of K14 in Bladder Cancer With a Non Invasive Technique
K14 in Urothelial Cells as a Pronostic and Diagnostic Marker in Bladder Cancer Patients Using a Non Invasive Technique.
NCT02027649CI-TRIAL-00028724terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Absence of positive results
Summary
Brief summary (as posted)
By an invasive technique keratin 14 has been identified as a prognostic factor in bladder cancer. This study aims to analyze whether through a non-invasive technique keratin 14 can be used as a diagnostic and prognostic marker for this cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Bladder cancer
- description
- Patients who suffered a bladder cancer
- label
- Control group
- description
- Patients with urologic diseases of non tumoral origin
Primary outcomes (1)
- measure
- Keratin 14
- timeFrame
- At the time of study entry
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Bladder cancer Exclusion Criteria: * Inability to sign the informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.